243 related articles for article (PubMed ID: 30309383)
1. No association of TP53 codon 72 and intron 3 16-bp duplication polymorphisms with breast cancer risk in Chinese Han women: new evidence from a population-based case-control investigation.
Hao W; Xu X; Shi H; Zhang C; Chen X
Eur J Med Res; 2018 Oct; 23(1):47. PubMed ID: 30309383
[TBL] [Abstract][Full Text] [Related]
2. Lack of association of intron 3 16 bp polymorphism of TP53 with breast cancer among Iranian-Azeri patients.
Pouladi N; Kouhsari SM; Feizi MH; Dehghan R; Azarfam P; Farajzadeh D
Asian Pac J Cancer Prev; 2014; 15(6):2631-4. PubMed ID: 24761875
[TBL] [Abstract][Full Text] [Related]
3. Analysis of polymorphisms in codons 11, 72 and 248 of TP53 in Brazilian women with breast cancer.
Almeida BC; Kleine JP; Camargo-Kosugi CM; Lisboa MR; França CN; França JP; Silva ID
Genet Mol Res; 2016 Feb; 15(1):. PubMed ID: 26909997
[TBL] [Abstract][Full Text] [Related]
4. TP53 codon 72 polymorphism and breast cancer risk in Bangladeshi population.
Hossain A; Murshid GMM; Zilani MNH; Islam F; Sultana R; Sultana T; Hossain MG; Rahman MM
Breast Cancer; 2017 Jul; 24(4):571-578. PubMed ID: 27837441
[TBL] [Abstract][Full Text] [Related]
5. Lack of influence of TP53 Arg72Pro and 16bp duplication polymorphisms on risk of breast cancer in Iran.
Gohari-Lasaki S; Gharesouran J; Ghojazadeh M; Montazeri V; Mohaddes Ardebili SM
Asian Pac J Cancer Prev; 2015; 16(7):2971-4. PubMed ID: 25854391
[TBL] [Abstract][Full Text] [Related]
6. Codon 72 and G13964C intron 6 polymorphisms of TP53 in relation to development and progression of breast cancer in India.
Surekha D; Sailaja K; Rao DN; Padma T; Raghunadharao D; Vishnupriya S
Asian Pac J Cancer Prev; 2011; 12(8):1893-8. PubMed ID: 22292621
[TBL] [Abstract][Full Text] [Related]
7. Effect of TP53 16-bp and β-TrCP 9-bp INS/DEL polymorphisms in relation to risk of breast cancer.
Eskandari-Nasab E; Hashemi M; Amininia S; Ebrahimi M; Rezaei M; Hashemi SM
Gene; 2015 Sep; 568(2):181-5. PubMed ID: 26003292
[TBL] [Abstract][Full Text] [Related]
8. TP53 Gene 72 Arg/Pro (rs1042522) Single Nucleotide Polymorphism Contribute to Increase the Risk of B-Chronic Lymphocytic Leukemia in the Sudanese Population.
Mohammed Basabaeen AA; Abdelgader EA; Babekir EA; Abdelrahim SO; Eltayeb NH; Altayeb OA; Fadul EA; Sabo A; Ibrahim IK
Asian Pac J Cancer Prev; 2019 May; 20(5):1579-1585. PubMed ID: 31128065
[TBL] [Abstract][Full Text] [Related]
9. Breast cancer risk in relation to TP53 codon 72 and CDH1 gene polymorphisms in the Bangladeshi women.
Shabnaz S; Ahmed MU; Islam MS; Islam MR; Al-Mamun MM; Islam MS; Hasnat A
Tumour Biol; 2016 Jun; 37(6):7229-37. PubMed ID: 26666818
[TBL] [Abstract][Full Text] [Related]
10. TP53 polymorphisms in gliomas from Indian patients: Study of codon 72 genotype, rs1642785, rs1800370 and 16 base pair insertion in intron-3.
Jha P; Jha P; Pathak P; Chosdol K; Suri V; Sharma MC; Kumar G; Singh M; Mahapatra AK; Sarkar C
Exp Mol Pathol; 2011 Apr; 90(2):167-72. PubMed ID: 21115003
[TBL] [Abstract][Full Text] [Related]
11. TP53 codon 72 polymorphism contributes to nasopharyngeal cancer susceptibility: a meta-analysis.
Zhuo XL; Cai L; Xiang ZL; Zhuo WL; Wang Y; Zhang XY
Arch Med Res; 2009 May; 40(4):299-305. PubMed ID: 19608020
[TBL] [Abstract][Full Text] [Related]
12. Three common TP53 polymorphisms in susceptibility to breast cancer, evidence from meta-analysis.
Hu Z; Li X; Yuan R; Ring BZ; Su L
Breast Cancer Res Treat; 2010 Apr; 120(3):705-14. PubMed ID: 19657731
[TBL] [Abstract][Full Text] [Related]
13. Association between the TP53 polymorphisms and lung cancer risk: a meta-analysis.
Ye XH; Bu ZB; Feng J; Peng L; Liao XB; Zhu XL; Sun XL; Yu HG; Yan DF; Yan SX
Mol Biol Rep; 2014 Jan; 41(1):373-85. PubMed ID: 24271138
[TBL] [Abstract][Full Text] [Related]
14. Polymorphism of TP53 codon 72 showed no association with breast cancer in Iranian women.
Khadang B; Fattahi MJ; Talei A; Dehaghani AS; Ghaderi A
Cancer Genet Cytogenet; 2007 Feb; 173(1):38-42. PubMed ID: 17284368
[TBL] [Abstract][Full Text] [Related]
15. Association between polymorphisms in apoptotic genes and susceptibility for developing breast cancer in Syrian women.
Lajin B; Alhaj Sakur A; Alachkar A
Breast Cancer Res Treat; 2013 Apr; 138(2):611-9. PubMed ID: 23468244
[TBL] [Abstract][Full Text] [Related]
16. TP53 gene polymorphisms at codons 11, 72, and 248 and association with endometriosis in a Brazilian population.
Camargo-Kosugi CM; D'Amora P; Kleine JP; Carvalho CV; Sato H; Schor E; Silva ID
Genet Mol Res; 2014 Aug; 13(3):6503-11. PubMed ID: 25177931
[TBL] [Abstract][Full Text] [Related]
17. A single-nucleotide polymorphism in the TP53 and MDM-2 gene modifies breast cancer risk in an ethnic Arab population.
Alshatwi AA; Hasan TN; Shafi G; Alsaif MA; Al-Hazzani AA; Alsaif AA
Fundam Clin Pharmacol; 2012 Jun; 26(3):438-43. PubMed ID: 21477265
[TBL] [Abstract][Full Text] [Related]
18. Importance of TP53 codon 72 and intron 3 duplication 16 bp polymorphisms and their haplotypes in susceptibility to sarcopenia in Iranian older adults.
Montazeri-Najafabady N; Dabbaghmanesh MH; Nasimi N; Sohrabi Z; Estedlal A; Asmarian N
BMC Geriatr; 2022 Feb; 22(1):103. PubMed ID: 35123410
[TBL] [Abstract][Full Text] [Related]
19. Association of TP53 Codon 72 Arg>Pro Polymorphism with Breast and Lung Cancer Risk in the South Asian Population: A Meta-Analysis.
Jafrin S; Aziz MA; Anonna SN; Akter T; Naznin NE; Reza S; Islam MS
Asian Pac J Cancer Prev; 2020 Jun; 21(6):1511-1519. PubMed ID: 32592343
[TBL] [Abstract][Full Text] [Related]
20. Importance of TP53 codon 72 and intron 3 duplication 16bp polymorphisms in prediction of susceptibility on breast cancer.
Costa S; Pinto D; Pereira D; Rodrigues H; Cameselle-Teijeiro J; Medeiros R; Schmitt F
BMC Cancer; 2008 Jan; 8():32. PubMed ID: 18230179
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
